E
Acutus Medical, Inc.
AFIB
$0.107
-$0.0377-26.05%
E
Sell
3/14/2023Downgrade
Acutus Medical, Inc. (AFIB) was downgraded to E+ from D- on 03/14/2023.
Acutus Medical, Inc. (AFIB) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
Acutus Medical, Inc. (AFIB) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.
Acutus Medical, Inc. (AFIB) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index.
E
Sell
2/8/2023Downgrade
Acutus Medical, Inc. (AFIB) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index and valuation index.
Acutus Medical, Inc. (AFIB) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index and valuation index.
D
Sell
11/15/2022Downgrade
Acutus Medical, Inc. (AFIB) was downgraded to D- from D on 11/15/2022 due to a noticeable decline in the solvency index and growth index. Earnings per share declined from $0.1595 to -$0.7202, debt to equity increased from 0.45 to 0.6, and operating cash flow declined 15.65% from -$20.61M to -$23.84M.
Acutus Medical, Inc. (AFIB) was downgraded to D- from D on 11/15/2022 due to a noticeable decline in the solvency index and growth index. Earnings per share declined from $0.1595 to -$0.7202, debt to equity increased from 0.45 to 0.6, and operating cash flow declined 15.65% from -$20.61M to -$23.84M.
D
Sell
7/20/2022Upgraded
Acutus Medical, Inc. (AFIB) was upgraded to D from D- on 7/20/2022 due to an increase in the volatility index, growth index and total return index. EBIT increased 0.11% from -$30.28M to -$30.25M.
Acutus Medical, Inc. (AFIB) was upgraded to D from D- on 7/20/2022 due to an increase in the volatility index, growth index and total return index. EBIT increased 0.11% from -$30.28M to -$30.25M.
D
Sell
5/5/2022Upgraded
Acutus Medical, Inc. (AFIB) was upgraded to D- from E+ on 05/05/2022.
Acutus Medical, Inc. (AFIB) was upgraded to D- from E+ on 05/05/2022.
E
Sell
4/20/2022Downgrade
Acutus Medical, Inc. (AFIB) was downgraded to E+ from D- on 4/20/2022 due to a decline in the volatility index, growth index and solvency index. Debt to equity increased from 0.3 to 0.39, the quick ratio declined from 7.44 to 5.69, and earnings per share declined from -$0.936 to -$1.1184.
Acutus Medical, Inc. (AFIB) was downgraded to E+ from D- on 4/20/2022 due to a decline in the volatility index, growth index and solvency index. Debt to equity increased from 0.3 to 0.39, the quick ratio declined from 7.44 to 5.69, and earnings per share declined from -$0.936 to -$1.1184.
D
Sell
3/4/2022Downgrade
Acutus Medical, Inc. (AFIB) was downgraded to D- from D on 3/4/2022 due to a decline in the volatility index and total return index.
Acutus Medical, Inc. (AFIB) was downgraded to D- from D on 3/4/2022 due to a decline in the volatility index and total return index.
D
Sell
1/19/2022Upgraded
Acutus Medical, Inc. (AFIB) was upgraded to D from D- on 1/19/2022 due to an increase in the volatility index.
Acutus Medical, Inc. (AFIB) was upgraded to D from D- on 1/19/2022 due to an increase in the volatility index.
D
Sell
1/3/2022Downgrade
Acutus Medical, Inc. (AFIB) was downgraded to D- from D on 1/3/2022 due to a decline in the volatility index and total return index.
Acutus Medical, Inc. (AFIB) was downgraded to D- from D on 1/3/2022 due to a decline in the volatility index and total return index.
D
Sell
12/13/2021Upgraded
Acutus Medical, Inc. (AFIB) was upgraded to D from D- on 12/13/2021 due to an increase in the volatility index.
Acutus Medical, Inc. (AFIB) was upgraded to D from D- on 12/13/2021 due to an increase in the volatility index.
D
Sell
11/26/2021Downgrade
Acutus Medical, Inc. (AFIB) was downgraded to D- from D on 11/26/2021 due to a decline in the volatility index, growth index and total return index. Operating cash flow declined 14.99% from -$23.64M to -$27.19M, EBIT declined 5.39% from -$27.56M to -$29.04M, and total revenue declined 2.29% from $4.71M to $4.6M.
Acutus Medical, Inc. (AFIB) was downgraded to D- from D on 11/26/2021 due to a decline in the volatility index, growth index and total return index. Operating cash flow declined 14.99% from -$23.64M to -$27.19M, EBIT declined 5.39% from -$27.56M to -$29.04M, and total revenue declined 2.29% from $4.71M to $4.6M.
D
Sell
11/9/2021Upgraded
Acutus Medical, Inc. (AFIB) was upgraded to D from E+ on 11/09/2021.
Acutus Medical, Inc. (AFIB) was upgraded to D from E+ on 11/09/2021.
E
Sell
11/8/2021Downgrade
Acutus Medical, Inc. (AFIB) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index and solvency index.
Acutus Medical, Inc. (AFIB) was downgraded to E+ from D on 11/8/2021 due to a decline in the total return index and solvency index.
D
Sell
9/1/2021Upgraded
Acutus Medical, Inc. (AFIB) was upgraded to D from D- on 9/1/2021 due to an increase in the growth index. Total revenue increased 31.13% from $3.59M to $4.71M, operating cash flow increased 10.01% from -$26.27M to -$23.64M, and EBIT increased 4.93% from -$28.99M to -$27.56M.
Acutus Medical, Inc. (AFIB) was upgraded to D from D- on 9/1/2021 due to an increase in the growth index. Total revenue increased 31.13% from $3.59M to $4.71M, operating cash flow increased 10.01% from -$26.27M to -$23.64M, and EBIT increased 4.93% from -$28.99M to -$27.56M.
D
Sell
5/3/2021Upgraded
Acutus Medical, Inc. (AFIB) was upgraded to D- from E on 5/3/2021 due to an increase in the growth index and valuation index. Earnings per share increased from -$1.9457 to -$1.0539, and operating cash flow increased 8.17% from -$26.28M to -$24.13M.
Acutus Medical, Inc. (AFIB) was upgraded to D- from E on 5/3/2021 due to an increase in the growth index and valuation index. Earnings per share increased from -$1.9457 to -$1.0539, and operating cash flow increased 8.17% from -$26.28M to -$24.13M.
E
Sell
2/5/2021Upgraded
Acutus Medical, Inc. (AFIB) was upgraded to E from E- on 2/5/2021 due to an increase in the valuation index and total return index.
Acutus Medical, Inc. (AFIB) was upgraded to E from E- on 2/5/2021 due to an increase in the valuation index and total return index.
E
Sell
1/21/2021Downgrade
Acutus Medical, Inc. (AFIB) was downgraded to E- from E on 1/21/2021 due to a noticeable decline in the volatility index.
Acutus Medical, Inc. (AFIB) was downgraded to E- from E on 1/21/2021 due to a noticeable decline in the volatility index.
E
Sell
1/6/2021Upgraded
Acutus Medical, Inc. (AFIB) was upgraded to E from E- on 1/6/2021 due to an increase in the volatility index.
Acutus Medical, Inc. (AFIB) was upgraded to E from E- on 1/6/2021 due to an increase in the volatility index.
E
Sell
12/22/2020Downgrade
Acutus Medical, Inc. (AFIB) was downgraded to E- from E on 12/22/2020 due to a decline in the valuation index and volatility index.
Acutus Medical, Inc. (AFIB) was downgraded to E- from E on 12/22/2020 due to a decline in the valuation index and volatility index.
E
Sell
11/20/2020Upgraded
Acutus Medical, Inc. (AFIB) was upgraded to E from E- on 11/20/2020 due to a significant increase in the solvency index, total return index and efficiency index. The quick ratio increased from 0.96 to 9.93, and total capital increased 414.85% from $37.62M to $193.68M.
Acutus Medical, Inc. (AFIB) was upgraded to E from E- on 11/20/2020 due to a significant increase in the solvency index, total return index and efficiency index. The quick ratio increased from 0.96 to 9.93, and total capital increased 414.85% from $37.62M to $193.68M.
E
Sell
10/29/2020None
Acutus Medical, Inc. (AFIB) was downgraded to E- from U on 10/29/2020.
Acutus Medical, Inc. (AFIB) was downgraded to E- from U on 10/29/2020.
NASDAQ
05/06/2024 4:00PM Eastern
Quotes delayed
